Maatschap Cardiologie Zwolle Report issue

Academic/Hospital
Founded: Zwolle Netherlands (1982)

Organization Overview

First Clinical Trial
2019
NCT03845010
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Maatschap Cardiologie Zwolle

Active Ingredients

Drugs in Other Trials (3)

flecainide (tambocor) (1 trial)

sotalol (betapace) (1 trial)

verapamil (calan) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 3